Financials in USD. Standardized financial statements.
A compact view of how Lattice Biologics Ltd. turns revenue into operating income and net income.
| Metric | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.46M | $2.19M | $1.16M | $2.74M | $3.78M | $4,188.138 | $6,113 | $0 | $0 | $0 |
| Revenue Growth? | +12.6% | +89.5% | -57.8% | -27.5% | +90107.2% | -31.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $1.44M | $1.25M | $613,887 | $2.17M | $2.96M | $3,350.582 | $4,737 | $0 | $0 | $0 |
| Gross Profit? | $1.02M | $942,761 | $541,154 | $571,110 | $816,693 | $837.556 | $1,376 | $0 | $0 | $0 |
| Gross Margin? | +41.4% | +43.1% | +46.9% | +20.9% | +21.6% | +20.0% | +22.5% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $1.36M | $1.51M | $1.87M | $3.16M | $4.27M | $4,145.218 | $165,100 | $200,442 | $245,116 | $428,514 |
| Operating Income? | -$336,000 | -$565,000 | -$1.33M | -$2.59M | -$3.45M | -$2,631.462 | -$165,000 | -$200,000 | -$245,000 | -$428,514.202 |
| EBITDA? | -$58,301 | -$264,000 | -$563,000 | -$876,000 | -$6.33M | -$2.17M | -$519,000 | -$484,000 | -$557,000 | -$27.65M |
| Income Before Tax | -$1.48M | -$1.01M | -$1.23M | -$1.52M | -$7.85M | -$4,057.766 | -$518,000 | -$489,000 | -$562,000 | -$27.67M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$351 | $0 | -$154,000 | $4,979.432 |
| Net Income? | -$1.48M | -$1.01M | -$1.23M | -$1.52M | -$7.85M | -$4,057.766 | -$519,000 | -$489,000 | -$407,000 | -$27.59M |
| EPS? | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.16 | $-0.15 | $-0.26 | $-0.24 | $-0.20 | $-13.70 |
| Diluted EPS? | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.16 | $-0.15 | $-0.26 | $-0.24 | $-0.20 | $-13.70 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality